Vimarsana
Biggest News Aggregation in the World

Page 17 - Umer Raffat News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Umer Raffat. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Umer Raffat Today - Breaking & Trending Today

Merck Stock: The Battle Among Weight-Loss Drugs Has A New Contender - Vimarsana News

Merck Stock: The Battle Among Weight-Loss Drugs Has A New Contender

Merck stock wavered Tuesday after unveiling new data for a potential competitor to weight-loss drugs from Novo Nordisk and Eli Lilly.

Insurers clamping down on doctors who prescribe Ozempic for weight loss – Indianapolis Business Journal - Vimarsana News

Insurers clamping down on doctors who prescribe Ozempic for weight loss – Indianapolis Business Journal

Indianapolis-based Elevance Health, which operates Anthem plans, said that in most cases, it won't cover Ozempic unless a patient is diagnosed with diabetes and has tried another medication to manage it, but physicians can still prescribe it.

Source: ibj.com
Pfizer says hemophilia drug succeeded in Phase 3 study - Vimarsana News

Pfizer says hemophilia drug succeeded in Phase 3 study

BioPharma

Analysts are Upgrading These 10 Stocks - Insider Monkey - Vimarsana News

Analysts are Upgrading These 10 Stocks - Insider Monkey

US stock markets are wavering as politicians continue their talks about the debt ceiling problem.

Teva puts rival to Prometheus, Pfizer drugs at center of turnaround plans - Vimarsana News

Teva puts rival to Prometheus, Pfizer drugs at center of turnaround plans

BioPharma